KP-77 (The Kalm Patch)

About Kalm Therapeutics

Kalm Therapeutics is developing KP-77, a novel once-daily prescription patch designed to treat eczema and psoriasis. The patch combines physical skin protection with continuous, controlled delivery of a plant-based anti-inflammatory active ingredient, aiming to improve upon current messy creams and steroid treatments. The company is in the preclinical stage, targeting a significant unmet need in the dermatology market with a differentiated, patient-friendly product. Its approach leverages a proprietary drug delivery platform to create a therapeutic patch that addresses both symptom management and disease drivers like skin barrier dysfunction.

Therapeutic Areas